Chemical inhibitors of α T-catenin can modulate its function through various molecular mechanisms. Bisindolylmaleimide I and Gö 6983 target the Protein Kinase C (PKC), a family of enzymes that play a crucial role in several cellular processes including those involving α T-catenin. By inhibiting PKC, these compounds can alter the signaling pathways essential for the proper functioning of α T-catenin, particularly those linked to the actin cytoskeleton dynamics and cell adhesion properties. Another inhibitor, Y-27632, acts on the Rho-associated protein kinase (ROCK), a key regulator of the actin cytoskeleton. The inhibition of ROCK by Y-27632 can disrupt the interaction of α T-catenin with the actin cytoskeleton, consequently affecting cell shape and motility. Similarly, ML-7, by targeting myosin light chain kinase (MLCK), can impede the cytoskeletal rearrangements crucial for the functions of α T-catenin, leading to changes in cellular adhesion and morphology.
Moreover, Blebbistatin, which impedes myosin II ATPase activity, can affect processes involving muscle contraction and cellular motility where α T-catenin is involved. The influence of Blebbistatin on myosin II can lead to the inhibition of α T-catenin's role in cell-cell adhesion. KN-93, which inhibits Ca2+/calmodulin-dependent protein kinase II (CaMKII), can disrupt calcium-dependent signaling processes crucial for the role of α T-catenin in cardiomyocytes. W-7 takes a similar approach by inhibiting calmodulin, a protein that interacts with various signaling molecules, thus affecting Ca2+-dependent signaling pathways linked to α T-catenin. On another front, LY294002 and Wortmannin, both phosphoinositide 3-kinases (PI3K) inhibitors, can disrupt signaling pathways that are essential for the stability of cell-cell junctions where α T-catenin plays a pivotal role. Finally, PD 98059, SB203580, and SP600125, which inhibit MEK, p38 MAPK, and JNK, respectively, can disrupt various signaling pathways, including those involved in stress response and cellular adhesion, implicating the functional inhibition of α T-catenin in these processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Inhibits Protein Kinase C (PKC) which is involved in the signaling pathways that α T-catenin participates in, leading to the functional inhibition of α T-catenin by altering the actin cytoskeleton dynamics and cell adhesion properties. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibits Rho-associated protein kinase (ROCK), which modulates the actin cytoskeleton and cell adhesion; inhibition of ROCK can disrupt the interaction of α T-catenin with the actin cytoskeleton, thereby inhibiting its function. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
Inhibits myosin light chain kinase (MLCK) which is crucial for cytoskeletal rearrangements; by inhibiting MLCK, the cytoskeletal interactions of α T-catenin can be disrupted, leading to its functional inhibition. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $72.00 $265.00 $495.00 $968.00 | ||
Inhibits myosin II ATPase activity, affecting muscle contraction and cellular motility processes that α T-catenin is involved in; this results in the inhibition of α T-catenin's role in cell-cell adhesion. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Inhibits Protein Kinase C (PKC) which could disrupt signaling pathways affecting functions of α T-catenin, particularly in cell adhesion and signal transduction. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
Inhibits Ca2+/calmodulin-dependent protein kinase II (CaMKII); α T-catenin's function in cardiomyocytes involves Ca2+-dependent signaling, and inhibiting CaMKII can disrupt this, leading to functional inhibition of α T-catenin. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
Inhibits calmodulin, which interacts with various signaling molecules; by inhibiting calmodulin, the Ca2+-dependent signaling involving α T-catenin can be inhibited, affecting its function in cellular processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits phosphoinositide 3-kinases (PI3K), which are part of signaling pathways that α T-catenin is involved in for cell-cell junction stability, thus inhibiting its function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits phosphoinositide 3-kinases (PI3K), thereby disrupting downstream signaling that affects α T-catenin's role in maintaining cell-cell adhesion and cytoskeletal organization. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which in turn inhibits ERK/MAPK signaling; α T-catenin is implicated in pathways influenced by MAPK signaling, and by inhibiting this pathway, the function of α T-catenin can be inhibited. | ||||||